Galovan Scott Michael 4
4 · AVANOS MEDICAL, INC. · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Avanos (AVNS) CFO Scott Galovan Surrenders 4,228 Shares for Taxes
What Happened
- Scott Michael Galovan, CFO of Avanos Medical, had 12,225 time‑based restricted share units vest on April 22, 2026. To satisfy tax withholding obligations, 4,228 shares were surrendered to the company (disposition code F) at an implied value of $24.64 per share, totaling $104,178. This was a tax‑withholding share surrender (not an open‑market sale).
Key Details
- Transaction date: April 22, 2026; filing date: April 24, 2026 (timely)
- Shares surrendered: 4,228 at $24.64 per share; total value ≈ $104,178
- Vesting covered: 12,225 TRSUs awarded April 22, 2025 and vested April 22, 2026
- Net shares issued to insider after withholding (12,225 − 4,228): 7,997 (calculation based on filing data)
- Transaction code F = shares surrendered to satisfy tax withholding; not a market sale
- Shares owned after transaction: not specified in the Form 4
Context
- This is a routine cashless withholding to cover taxes on vested restricted stock units, common for executive compensation, and does not necessarily indicate a view on the company’s stock.
Insider Transaction Report
Form 4
Galovan Scott Michael
SVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
[F1]2026-04-22$24.64/sh−4,228$104,178→ 135,596 total
Footnotes (1)
- [F1]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 12,225 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on April 22, 2025 and (ii) vested on April 22, 2026. Each TRSU is the economic equivalent of one share of Common Stock.
Signature
/s/ John Hurley, as attorney-in-fact for Scott M. Galovan|2026-04-24